Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Do 'Known' QT-prolonging Medications Cause Major Adverse Cardiac Events in Hospitalized Adults? The QTP-MACE Study

NCT07374263 is registered in ClinicalTrials.gov with St. Joseph's Healthcare Hamilton as lead sponsor.

NCT NCT07374263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07374263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Do 'Known' QT-prolonging Medications Cause Major Adverse Cardiac Events in Hospitalized Adults? The QTP-MACE Study
Lead sponsor
St. Joseph's Healthcare Hamilton
Phase
Observational
Overall status
Recruiting
Start date
February 1, 2025
Completion date
December 31, 2027
Enrollment
Not reported
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acquired long qt, mace, medication safety, syncope, torsades de pointes, ventricular arrhythmias